Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule
- PMID: 1372370
- PMCID: PMC289052
- DOI: 10.1128/JVI.66.4.2527-2531.1992
Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule
Abstract
Cytotoxic T lymphocytes (CTL) recognize virus peptide fragments complexed with class I major histocompatibility complex (MHC) molecules on the surface of virus-infected cells. Recognition is mediated by a membrane-bound T-cell receptor (TCR) composed of alpha and beta chains. Studies of the CTL response to lymphocytic choriomeningitis virus (LCMV) in H-2b mice have revealed that three distinct viral epitopes are recognized by CTL of the H-2b haplotype and that all of the three epitopes are restricted by the Db MHC molecule. The immunodominant Db-restricted CTL epitope, located at LCMV glycoprotein amino acids 278 to 286, was earlier noted to be recognized by TCRs that consistently contained V alpha 4 segments but had heterogeneous V beta segments. Here we show that CTL clones recognizing the other two H-2Db-restricted epitopes, LCMV glycoprotein amino acids 34 to 40 and nucleoprotein amino acids 397 to 407 (defined in this study), utilize TCR alpha chains which do not belong to the V alpha 4 subfamily. Hence, usage of V alpha and V beta in the TCRs recognizing peptide fragments from one virus restricted by a single MHC molecule is not sufficiently homogeneous to allow manipulation of the anti-viral CTL response at the level of TCRs. The diversity of anti-viral CTL likely provides the host with a wider option for attacking virus-infected cells and prevents the emergence of virus escape mutants that might arise if TCRs specific for the virus were homogeneous.
Similar articles
-
Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.J Virol. 1990 Dec;64(12):5919-26. doi: 10.1128/JVI.64.12.5919-5926.1990. J Virol. 1990. PMID: 1700830 Free PMC article.
-
Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.Eur J Immunol. 1990 Mar;20(3):523-31. doi: 10.1002/eji.1830200310. Eur J Immunol. 1990. PMID: 2138558
-
Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.J Exp Med. 1988 Aug 1;168(2):559-70. doi: 10.1084/jem.168.2.559. J Exp Med. 1988. PMID: 2457647 Free PMC article.
-
Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen.Cancer Sci. 2004 Jun;95(6):469-74. doi: 10.1111/j.1349-7006.2004.tb03234.x. Cancer Sci. 2004. PMID: 15182425 Free PMC article. Review.
-
Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?Immunol Rev. 1998 Aug;164(1):37-51. doi: 10.1111/j.1600-065x.1998.tb01206.x. Immunol Rev. 1998. PMID: 9795762 Free PMC article. Review.
Cited by
-
Vaccination to prevent persistent viral infection.J Virol. 1993 Jul;67(7):4372-8. doi: 10.1128/JVI.67.7.4372-4378.1993. J Virol. 1993. PMID: 8510226 Free PMC article.
-
Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen.J Virol. 1995 May;69(5):3134-46. doi: 10.1128/JVI.69.5.3134-3146.1995. J Virol. 1995. PMID: 7535867 Free PMC article.
-
A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9281-6. doi: 10.1073/pnas.96.16.9281. Proc Natl Acad Sci U S A. 1999. PMID: 10430934 Free PMC article.
-
Postexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2725-30. doi: 10.1073/pnas.040575197. Proc Natl Acad Sci U S A. 2000. PMID: 10694575 Free PMC article.
-
Virus-specific CD8+ T-cell responses in mice transgenic for a T-cell receptor beta chain selected at random.J Virol. 1994 May;68(5):3065-70. doi: 10.1128/JVI.68.5.3065-3070.1994. J Virol. 1994. PMID: 7908699 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous